| P50 | author | Dita Gratzinger | Q40447127 |
| | Michael Corces | Q43092568 |
| | Dirk Strunk | Q45503167 |
| | Katharina Schallmoser | Q50648053 |
| | Andreas Reinisch | Q56930266 |
| P2093 | author name string | Ravindra Majeti | |
| | Daniel Thomas | |
| | Xiaohua Zhang | |
| | Wan-Jen Hong | |
| | M Ryan Corces | |
| P2860 | cites work | Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2 | Q24568313 |
| | Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood | Q24656265 |
| | Hematopoietic stem cell niche maintenance during homeostasis and regeneration | Q26865273 |
| | Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell | Q27861001 |
| | Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement | Q27861120 |
| | Xenograft models for normal and malignant stem cells | Q28087038 |
| | A cell initiating human acute myeloid leukaemia after transplantation into SCID mice | Q28131777 |
| | Identification of the haematopoietic stem cell niche and control of the niche size | Q29615008 |
| | A gain-of-function mutation of JAK2 in myeloproliferative disorders | Q29618851 |
| | Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders | Q29618853 |
| | Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia. | Q33560404 |
| | Development and function of human innate immune cells in a humanized mouse model | Q33596915 |
| | AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3 | Q33713705 |
| | An in vivo model to study and manipulate the hematopoietic stem cell niche | Q33780248 |
| | Somatic mutations of calreticulin in myeloproliferative neoplasms | Q34039270 |
| | Some speculations on the myeloproliferative syndromes. | Q34296252 |
| | Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission | Q34405195 |
| | Identification of therapeutic targets for quiescent, chemotherapy-resistant human leukemia stem cells | Q34421127 |
| | Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rγc-deficient mice | Q34428887 |
| | Sequential treatment of CD34+ cells from patients with primary myelofibrosis with chromatin-modifying agents eliminate JAK2V617F-positive NOD/SCID marrow repopulating cells. | Q34541582 |
| | Human thrombopoietin knockin mice efficiently support human hematopoiesis in vivo | Q34572945 |
| | Human IL-3/GM-CSF knock-in mice support human alveolar macrophage development and human immune responses in the lung | Q34573221 |
| | Epigenetic and in vivo comparison of diverse MSC sources reveals an endochondral signature for human hematopoietic niche formation | Q34876718 |
| | Establishment of a humanized APL model via the transplantation of PML-RARA-transduced human common myeloid progenitors into immunodeficient mice | Q35391634 |
| | Acute promyelocytic leukemia: where does it stem from? | Q35635316 |
| | A PMLRARalpha transgene initiates murine acute promyelocytic leukemia | Q36049975 |
| | Spleens of myelofibrosis patients contain malignant hematopoietic stem cells | Q36356466 |
| | Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes | Q36637556 |
| | Functional heterogeneity of genetically defined subclones in acute myeloid leukemia | Q37698123 |
| | Improving human hemato-lymphoid-system mice by cytokine knock-in gene replacement | Q37893316 |
| | Hematopoiesis: a human perspective | Q37981372 |
| | Normal and leukemic stem cell niches: insights and therapeutic opportunities. | Q38369894 |
| | Tuning cytokine receptor signaling by re-orienting dimer geometry with surrogate ligands | Q38625843 |
| | A robust xenotransplantation model for acute myeloid leukemia | Q40886338 |
| | Cell lineage involvement of recurrent chromosomal abnormalities in hematologic neoplasms | Q41466155 |
| | Anabolic actions of PTH (1-34): use of a novel tissue engineering model to investigate temporal effects on bone | Q46283835 |
| | Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum. | Q46488249 |
| | Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment. | Q50676184 |
| | PML/RAR alpha fusion protein expression in normal human hematopoietic progenitors dictates myeloid commitment and the promyelocytic phenotype. | Q51076563 |
| | Stem cell gene expression programs influence clinical outcome in human leukemia. | Q51856192 |
| | Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unit. | Q52877857 |
| | CD19-CD45 low/- CD38 high/CD138+ plasma cells enrich for human tumorigenic myeloma cells. | Q53370464 |
| | Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. | Q53520724 |
| | Behavior of CD34+ cells isolated from patients with polycythemia vera in NOD/SCID mice. | Q53530978 |
| | Highly purified primitive hematopoietic stem cells are PML-RARA negative and generate nonclonal progenitors in acute promyelocytic leukemia. | Q54175138 |
| | Reconstructing the human hematopoietic niche in immunodeficient mice: opportunities for studying primary multiple myeloma | Q56908656 |
| | Successful xenografts of AML3 samples in immunodeficient NOD/shi-SCID IL2Rγ−/− mice | Q58125472 |
| | Coexistence of LMPP-like and GMP-like Leukemia Stem Cells in Acute Myeloid Leukemia | Q64008436 |
| | The total marrow mass of the mouse: a simplified method of measurement | Q71316089 |
| | PML/RAR alpha fusion gene is expressed in both granuloid/macrophage and erythroid colonies in acute promyelocytic leukaemia | Q72311480 |
| | Cell lineage specific involvement in acute promyelocytic leukaemia (APL) using a combination of May-Grünwald-Giemsa staining and fluorescence in situ hybridization techniques for the detection of the translocation t(15;17)(q22;q12) | Q77476747 |
| | NOD/SCID mice engineered to express human IL-3, GM-CSF and Steel factor constitutively mobilize engrafted human progenitors and compromise human stem cell regeneration | Q79309659 |
| | The hematopoietic stem cell compartment of JAK2V617F-positive myeloproliferative disorders is a reflection of disease heterogeneity | Q81606570 |
| | Anti-CD47 antibodies promote phagocytosis and inhibit the growth of human myeloma cells | Q84251637 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bone marrow | Q546523 |
| | leukemia | Q29496 |
| P304 | page(s) | 812-821 | |
| P577 | publication date | 2016-05-23 | |
| P1433 | published in | Nature Medicine | Q1633234 |
| P1476 | title | A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells | |
| P478 | volume | 22 | |